Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06746623 · ClinicalTrials.gov registry record · NA
Nonendoscopic Screening for Barrett's Esophagus in Veterans Without Chronic Reflux
A NA study of Tobacco Use and Barrett Esophagus, sponsored by Louis Stokes VA Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 400
- Enrollment target
- 1
- Study location
NCT06746623: Recruiting NA study of Tobacco Use and Barrett Esophagus, sponsored by Louis Stokes VA Medical Center.
NCT06746623 is a NA study of Tobacco Use and Barrett Esophagus that is actively recruiting participants, run by Louis Stokes VA Medical Center. The registered enrollment target is 400 participants, roughly in line with the 374-participant average among 76 other Tobacco Use trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06746623, a NA study of Tobacco Use and Barrett Esophagus, is actively recruiting participants, sponsored by Louis Stokes VA Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 400 participants
- Enrollment target
- 1
- Study location
Study Summary
The veteran population is at increased risk for EAC and its precursor lesion, Barrett's esophagus (BE), due to increased prevalence of disease risk factors compared to the general population. BE is traditionally diagnosed only when patients undergo endoscopy with biopsies. However, due to the high cost of endoscopy and the lack of studies proving efficacy of screening, endoscopy to screen for BE is not routinely recommended. A simpler screening procedure similar to a pap smear would be an ideal way to sample the esophageal tissue for cancer and its precursor condition, BE. This study proposes a non-endoscopic detection method administered in outpatient offices which would increase subsequent endoscopic detection of BE. The study team will be enrolling veterans who do not have history of gastroesophageal reflux but have multiple risk factors for esophageal adenocarcinoma.
Primary Outcome
Results from enrollment visit
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Enrolled participants will complete Esocheck/Esoguard and diagnostic upper endoscopy.
Study Locations (1)
Ohio
- VA Northeast Ohio Healthcare System - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2025-04-11 |
| Est. Completion | 2028-12-31 |
| Phase | NA |
What NCT06746623 shows while recruiting
NCT06746623 is an interventional study that assigns participants to a tested intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 374-participant average among 76 other Tobacco Use trials with a reported enrollment target.
The record links to 5 conditions, with Tobacco Use appearing as the primary indexed condition, and to 1 intervention - of which Enrolled participants will complete Esocheck/Esoguard and diagnostic upper endoscopy. is the first listed.
NCT06746623 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT06746623 about?
NCT06746623 is a clinical study titled "Nonendoscopic Screening for Barrett's Esophagus in Veterans Without Chronic Reflux". The veteran population is at increased risk for EAC and its precursor lesion, Barrett's esophagus (BE), due to increased prevalence of disease risk factors compared to the general population. BE is traditionally diagnosed only when patients undergo endoscopy with biopsies. However, due to the high c...
What is the current status of trial NCT06746623?
This trial is currently recruiting. It is a NA study. The enrollment target is 400 participants. The study started on 2025-04-11. Estimated completion is 2028-12-31.
What conditions does trial NCT06746623 study?
This clinical trial studies the following conditions: Tobacco Use, Barrett Esophagus, Veterans, Obese Patients, Family History of Esophageal Cancer.
What interventions are being tested in trial NCT06746623?
The interventions under investigation include: Enrolled participants will complete Esocheck/Esoguard and diagnostic upper endoscopy. (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06746623?
This trial is sponsored by Louis Stokes VA Medical Center, which has 10 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06746623 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tobacco Use
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06746623's enrollment target sits among peer trials
400 17th of 76 higher than 59 of 76 other Tobacco Use trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Tobacco Use trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Opioids, Low Nicotine Cigarettes, and Chronic Pain
RECRUITING · NA
-
Reach Through Equitable Implementation in Utah
RECRUITING · NA
-
RTMS Targets Neural Circuits for Smoking Cessation
RECRUITING · NA
-
Cigar Legislation and Regulation in Tobacco for the Young (Project CLARITY)
RECRUITING · NA
-
Catalyzing Cigarette Smoking Cessation Through Harm Reduction Sampling Among People Unmotivated to Quit
RECRUITING · NA
-
Symptoms and Functions in Patients With COPD and Chronic Bronchitis Switching From CIG to THS
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01665326 · 400 participants
Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease
- NCT02108054 · 400 participants · NA
Behavioral and Functional Task Development, Implementation, and Testing
- NCT02216500 · 400 participants · NA
Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
- NCT02250352 · 400 participants
Core Biopsies for Establishing a Breast Tumor Tissue Repository
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI